Acta Pharmaceutica Sinica B
|
2026, 16(5): 3243-3248
• Highlight •
Urate transporters: Structural mechanisms and therapeutic opportunities in drug development
Full
Qian Yang1, Shujing Xu1, Xiaoyu Shi1, Jianxin Pang2, Ting Wu2, Peng Zhan1,3,4
Affiliations
1 Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China;
2 NMPA Key Laboratory for Research and Evaluation of Drug Metabolism &Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China;
3 State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China;
4 State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine (Tianjin Institute of Pharmaceutical Research), Tianjin 300301, China
doi: 10.1016/j.apsb.2026.01.037
Outline
Urate
/
Structural biology
/
URAT1
/
OAT1
/
GLUT9
Qian Yang, Shujing Xu, Xiaoyu Shi, Jianxin Pang, Ting Wu, Peng Zhan.
Urate transporters: Structural mechanisms and therapeutic opportunities in drug development[J].
Acta Pharmaceutica Sinica B,
2026
, 16
(5)
: 3243
-3248
.
DOI: 10.1016/j.apsb.2026.01.037
Year 2026 volume 16 Issue 5
PDF
6
4
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2026.01.037
- Receive Date:2025-08-20
- Online Date:2026-09-17